US Broker Ratings

Royalty Pharma (RPRX) Stock Report: Analysts See a 13% Upside Potential Amid Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) continues to make waves in the biotechnology sector with its unique business model that capitalizes on the vast potential of biopharmaceutical royalties. Based in New..

Centene Corporation (CNC) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential

Centene Corporation (NYSE: CNC) is a prominent player in the healthcare industry, with a market capitalization of $21.26 billion. Operating in the healthcare plans sector, Centene provides a variety of..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 13% Potential Upside in the Booming Biotech Sector

BeOne Medicines Ltd. (ONC), a Swiss-based biotechnology powerhouse, is capturing investor attention with its robust pipeline and a promising 13% potential upside, according to the latest analyst ratings. Positioned in..

Labcorp Holdings Inc. (LH) Stock Analysis: A Promising 8.21% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH), a major player in the healthcare sector, operates within the Diagnostics & Research industry, offering a broad spectrum of laboratory services. With a market capitalization..

Novartis AG (NVS) Stock Analysis: Navigating a Challenging Market with a 30.81% Return on Equity

Novartis AG (NVS), a titan in the healthcare sector, continues to make waves in the pharmaceutical industry with its robust portfolio of innovative treatments. Despite the current challenges reflected in..

Edwards Lifesciences (EW) Investor Outlook: Exploring a Potential 20.96% Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector, continues to captivate investor interest with its robust growth potential and innovative product offerings. Based in Irvine, California,..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A Strong Buy with 30.44% Upside Potential

Thermo Fisher Scientific Inc. (NYSE: TMO), a colossal entity in the healthcare sector, particularly in diagnostics and research, continues to capture the interest of investors. With a market capitalization of..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 68.74% Potential Upside for Investors

Veeva Systems Inc. (NYSE: VEEV), a titan in the healthcare sector focusing on health information services, is a company that continues to capture the attention of investors with its robust..

Alcon Inc. (ALC) Stock Analysis: Unveiling a Potential 11% Upside with Strong Buy Ratings

Alcon Inc. (NYSE: ALC) continues to captivate the healthcare investment arena with its promising growth trajectory and robust market position. As a key player in the medical instruments and supplies..

Agilent Technologies (A) Stock Analysis: A Promising 38% Upside in the Healthcare Sector

Agilent Technologies, Inc. (NYSE: A), a leader in the healthcare sector’s diagnostics and research industry, is drawing investor attention with a substantial market capitalization of $34.84 billion. Based in Santa..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 11.28% Potential Upside in the Biotech Sector

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) presents an intriguing opportunity for investors with a keen eye on the biotechnology sector. As a pioneering company focused on developing transformative medicines for serious..

Merck & Company, Inc. (MRK) Stock Analysis: Analyst Ratings Signal Strong Buy Potential Amidst Robust Growth

Merck & Company, Inc. (MRK), a titan in the healthcare sector, continues to capture investor attention with its formidable market presence and promising growth prospects. As a key player in..

GSK plc (GSK) Stock Analysis: Navigating Opportunities in the Healthcare Giant with a Robust 43.31% ROE

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, continues to capture investor interest with its impressive credentials. Headquartered in London, United Kingdom, GSK engages in the research, development,..

Danaher Corporation (DHR) Stock Analysis: Exploring a 26.45% Potential Upside in the Dynamic Healthcare Sector

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, stands out in the diagnostics and research industry with a formidable market capitalization of $148.1 billion. Despite a current price..

Pfizer, Inc. (PFE) Stock Analysis: A Glimpse into Potential 7.18% Upside with Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, remains a focal point for investors as it navigates the complex landscape of the pharmaceutical industry. With a market capitalization..

AbbVie Inc. (ABBV) Stock Analysis: Potential 10.44% Upside and Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a stalwart in the healthcare sector, continues to capture investor attention with its robust portfolio and promising growth potential. With a market capitalization of $397.33 billion,..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a $584 Billion Giant with a 9% Revenue Growth

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, holds a commanding presence in the drug manufacturing industry. With a market capitalization of $584.38 billion, it stands as..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 85% Potential Upside Sparks Investor Interest

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, is currently making waves in the biotech sector with its promising pipeline of cancer therapies. With a market capitalization of $1.1..

Abivax SA (ABVX) Investor Outlook: Assessing the 17.4% Upside Potential and Strategic Position in the Biotech Sector

Abivax SA (ABVX), a prominent player in the biotechnology sector, has recently captured the attention of investors, particularly with a remarkable potential upside of 17.4%. As a clinical-stage biotech company..

COMPASS Pathways (CMPS) Investor Outlook: Exploring a 135% Potential Upside in Mental Health Revolution

Investors keen on exploring the frontier of mental health treatment may find COMPASS Pathways Plc (NASDAQ: CMPS) an intriguing prospect. As a biotechnology company at the cutting edge of mental..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds